RFPL3 and breast cancer: In summary, our findings have shown that CBP coordinates with RFPL-3 to promote ASC-induced breast cancer cell proliferation by anchoring to the hTERT promoter and upregulating telomerase activity, which is activated by the MAPK/ERK signaling pathway (Figure 6).